Guest guest Posted March 22, 2011 Report Share Posted March 22, 2011 Journal Blood - PPV " Based upon these collective data, future efforts targeting BTK with the irreversible inhibitor PCI-32765 in clinical trials of CLL patients is warranted. " Abstract:http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-20\ 11-01-328484v1 or http://tinyurl.com/67o2tlj Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.